Utilities
| Parameter | Utility* | Source |
| Disutility for experiencing a pneumonia | 0.079 | Biere et al13 |
| Disutility for experiencing a chyle leakage† | 0 | Biere et al13 |
| Disutility for experiencing laryngeal nerve paresis† | 0 | Biere et al13 |
| Utility in the first 6 months in the no evidence of disease state | 0.729 (SD=0.259; n=32) | Biere et al13 |
| Utility after the first 6 months in the no evidence of disease state | 0.800 (SD=0.21; n=75) | Doherty et al12 |
| Utility in the residual LN metastases state | 0.780 (SD=0.2; n=30) | Doherty et al12 |
| Utility in the palliative care state | 0.740 (SD=0.19; n=26) | Doherty et al12 |
*β-distributions were assigned to the parameters for use in the probabilistic sensitivity analysis. The characteristics of the β-distribution are presented between brackets, as an SD and n.
†Patients with chyle leakage and laryngeal nerve paresis had a higher utility than patients without complications, therefore the disutility was zero.
.LN, lymph node.